Pharmacy benefit managers are driving up drug costs for millions of people, employers and the government. New York Times pharmaceutical reporter, Rebecca Robbins, explains how.
Related Posts
![](https://static01.nyt.com/images/2024/05/16/science/16mpox/16mpox-facebookJumbo.jpg)
C.D.C. Warns of a Resurgence of Mpox
With Pride events scheduled worldwide over the coming weeks, U.S. officials are bracing for a return of mpox, the infectious…
![](https://static01.nyt.com/images/2024/06/12/multimedia/12XP-ENDO-gztp/12XP-ENDO-gztp-facebookJumbo.jpg)
Akira Endo, Scholar of Statins That Reduce Heart Disease, Dies at 90
Akira Endo, a Japanese biochemist whose research on fungi helped to lay the groundwork for widely prescribed drugs that lower…
![](https://static01.nyt.com/images/2024/06/06/multimedia/06sp-artfortomorrow-heal-inyt-02-zgwc/06sp-artfortomorrow-heal-inyt-02-zgwc-facebookJumbo.jpg)
Art and the Power to Heal
Using her arms as a makeshift clapboard, a Sudanese woman in a black hijab and black-and-white caftan clapped her hands…